Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 13, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on February 9, 2007. Each individual acquired 8 shares through the personal contribution element and 8 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 14.56 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share transactions mentioned above.
Investor Verification Points
- Verify the share price of GBP 14.56 per Ordinary Share on February 9, 2007.
- Confirm the participation of the named directors in the ShareReward Plan entered on October 5, 2001.
- Review the total number of shares acquired (16 per individual) to ensure accurate record-keeping of director holdings.